Funding for this research was provided by:
National Basic Research Program of China (973 Program) (2016YFC0902800)
National Natural Science Foundation of China (81870112, 81770171)
the Key Project of Natural Science Foundation of China (81530006)
Shanghai Collaborative Innovation Program on Regenerative Medicine and Stem Cell Research (2019CXJQ01)
the Samuel Waxman Cancer Research Foundation
Innovative research team of high-level local universities in Shanghai
Received: 6 December 2019
Accepted: 4 June 2020
First Online: 18 June 2020
Ethics approval and consent to participate
: All animal experiments were approved by The Animal Care & Welfare Committee of Ruijin Hospital affiliated to Shanghai Jiao tong University School of Medicine. Patient samples preparation was approved by the Institutional Review Board of the Ruijin Hospital affiliated to Shanghai Jiao tong University School of Medicine.
: Not applicable.
: The authors declare that they have no competing interests.